BioSpace News Archive

Business

BiomX Announces the Appointment of Edward L. Williams to its Board of Directors

BiomX Inc., a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, announced the appointment of Edward L. Williams to its Board of Directors.

October 18, 2023
·
2 min read
Biotech Beach

Ovid Therapeutics and Ligand Pharmaceuticals Enter into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid’s Cash Runway into 2026

Ovid Therapeutics Inc. and Ligand Pharmaceuticals Incorporated announced that Ligand has acquired a 13 percent portion of the royalties and milestones owed to Ovid related to the potential approval and commercialization of soticlestat.

October 18, 2023
·
11 min read
Currax Pharmaceuticals: CONTRAVE®/MYSIMBA® demonstrates no increased risk in major adverse cardiac events in a large, long-term real-world evidence study

Currax Pharmaceuticals LLC (“Currax”) today announced top-line results from a Cardiovascular Health Outcomes Analysis (HOA).

October 18, 2023
·
3 min read
Biotech Beach

Regen BioPharma, Inc. Expects Second Phase of Confirmatory Study Shortly

Regen BioPharma, Inc. (OTC-PINK: RGBP) (OTC-PINK: RGBPP) is currently developing a genetic approach to regulating NR2F6 levels in human T cells.

October 18, 2023
·
2 min read
Genetown

Akebia Therapeutics Announces Five Poster Presentations at ASN Kidney Week 2023

Akebia Therapeutics ® today announced that it will present data at the American Society of Nephrology Kidney Week 2023 (ASN Kidney Week), which will take place at the Pennsylvania Convention Center in Philadelphia from November 2-5, 2023.

October 18, 2023
·
6 min read
BioCapital

Novavax Receives Full Marketing Authorization for Prototype COVID-19 Vaccine Nuvaxovid™ in United Kingdom

Novavax, Inc. today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom.

October 18, 2023
·
8 min read
Genetown

Enveric Biosciences Initiates GLP Toxicology & Safety Pharmacology Studies for Lead Candidate EB-373, a Next Generation Psilocin Prodrug Targeting Psychiatric Disorders

Key preclinical milestone designed to establish safety profile and maximum tolerated dose for anticipated clinical trial of EB-373.

October 18, 2023
·
5 min read
Biotech Beach

Ensysce Biosciences Announces Poster Presentation at the AAPS 2023 PharmSci 360

Ensysce Biosciences, Inc. today announced Dr. Dolly Jacob, Director Integrated Development Services of Quotient Sciences, will present the collaborative work of Ensysce and Quotient Sciences in a poster.

October 18, 2023
·
4 min read
Genetown

Yield10 Bioscience Exercises Option to Finalize an Exclusive, Global Commercial License to Advanced Omega-3 Camelina Technology from Rothamsted Research

Yield10 Bioscience, Inc. today announced that the Company has exercised its option to finalize an exclusive global, commercial license to advanced omega-3 production technology from U.K.

October 18, 2023
·
6 min read
GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and Treatment

Genetic Technologies Limited, a global leader in genomics-based tests in health, wellness and serious disease, is pleased to announce the publication of a peer-reviewed research paper validating geneType’s Pancreatic Cancer risk assessment test.

October 18, 2023
·
3 min read